New iron formula could protect preterm infants from anemia

NCT ID NCT07667205

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a newer form of iron (liposomal iron) works better than standard iron drops to prevent iron deficiency anemia in premature babies. About 60 preterm infants born at or before 34 weeks will receive either daily standard iron, daily liposomal iron, or liposomal iron every other day. Researchers will measure blood levels of hemoglobin and iron stores to compare the approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

liposomal iron and ferrous iron (oral drops)

What this could lead to

If successful, this could point toward a better-tolerated or more effective way to prevent iron deficiency anemia in preterm infants.

What could go wrong

This is a very early phase 1 trial with only 60 participants, so results may not be conclusive. Liposomal iron is newer and may not prove superior to standard iron.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANEMIA IN PRETERM NEAONATES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain shams university

    Cairo, Egypt